PharmaTutor
18 May 2012

Multiple Jobs in Bengal Chemical & Pharmaceutical | Require Sales Representative, Medical Service Representative, Chief Manager/ Manager/ Dy. Manager (Purchase) - 15 posts

Bengal Chemical & Pharmaceutical Works Ltd.(BCPW)  is precursor of the present Company, Bengal Chemicals & Pharmaceuticals Ltd (BCPL).  Acharya P C Ray  took a rented house at 91 Upper Circular Road, Calcutta and started business with a meager capital of Rs 700.00. Since inception of the Company he was very much quality conscious and produced various products of British Pharmacopoeia standard.

18 May 2012
Job as Project Coordinator as Amneal Pharmaceuticals

Amneal Pharmaceuticals is a U.S. manufacturer of the highest quality generic pharmaceuticals. A dynamic and emergent company, we carefully nurture the entire product lifecycle-from the early stages of R&D and API development through FDA approval, painstakingly managed manufacturing and, ultimately, seamless supply to our customers.

Post: Project Coordinator

18 May 2012
Position of a Junior Research Fellow to work on DST sponsored project in Institute of Life Sciences

An Associate Institute of the University of Hyderabad, the Institute of Life Sciences (ILS) is a not-for-profit institute that aims to conduct innovative research in unifying areas of chemistry, biology and chemical biology.

18 May 2012
Walk in Interview : Opening as Junior Research Fellow in Sree Chitra Tirunal Institute for Medical Sciences & Technology

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram is an Institute of National Importance  established by an Act  of the Indian Parliament  and  under the 2 administrative control of the Department of Science and Technology, Government of India.

17 May 2012
Work as Medical Representative in Morepen Labs

Morepen’s state-of-art manufacturing facility in the picturesque environs of Baddi comprises a scientifically integrated complex of 10 plants, each with a specific product profile. The company’s extensive R&D facilities and factories are manned by a dedicated team of professionals who ensure stringent quality standards. Today Morepen is exporting products to several countries round the global.

17 May 2012
Opening for Head - Application Development Center in Manali Petrochemicals

Manali Petrochemicals Limited (MPL) is an India leader in the production and marketing of propylene oxide, propylene glycols and polyols that find widespread application in the pharmaceutical, food, fragrance, automobile, garments, refrigeration and the oil & gas industries. MPL's turnover for FY 2011 was INR 4530 million.

17 May 2012
Work as Scientist A - R&D in Hygro Chemicals and Pharmaceuticals

Hy-Gro set up its own manufacturing facility in Bollaram, India. This facility is ISO 9001-2000 and WHO-GMP compliant manufacturing Active Pharmaceutical Ingredients (APIs) and Drug Intermediates for both the domestic and international markets.
We are currently marketing our APIs and Drug Intermediates in 11 countries across the globe. Our customers include pharmaceutical majors in the regulated markets of Europe and the US.

17 May 2012
Require Dementia Practice Development Coach at The University of Worcester, UK

The University of Worcester is the second fastest growing HEI in the UK. It is a progressive, friendly institution, which currently welcomes over 8,500 full time and part time students a year; however, planned growth over the next five years will take the University closer to 12,000 students.

17 May 2012
PREVENTION OF NOSOCOMIAL INFECTIONS

About Authors:
*1P.SanilKumar, 1C K. Dhanapal, 2Sandhya Ravi
1Department of Pharmacy,
Annamali University, AnnamaliNager,
Chidambaram, Tamilnadu.
2Lotus Labs Pvt Ltd,
No.07, Jasmabhavan Road, Vasanthanager, Bangalore, Karnataka.
*sanilmpharm@gmail.com

ABSTRACT
Hospitals are created for cure the disease but not for the spreading of diseases, even though this statement is true to the theoretical concept but it is not possible practically due to various risk factors. The spread of infection in the hospitals occurs due to the microorganism. Nosocomial infections add significantly to the economic burden of managing the underlying disease that has lead to hospitalization of the patient. More than 90% of reported infections are bacterial where as viral, fungal or protozoal infections are less commonly involved in hospital-acquired infections. This project deals with bacterial nosocomial pathogens only, since they are by far major causes of nosocomial infections. Objective of the present study include  the identification, prevention and control of nosocomial infection in our hospitals. The ultimate aim is the reduction of nosocomial infections and their costs. Baseline study for morbidity pattern in the hospitals, finding sources of exogenous and endogenous sources of nosocomial infection. Suggest measures to minimize the nosocomial infections and suggest guidelines for efficacious management of nosocomial infections.

[adsense:336x280:8701650588]

16 May 2012
Walk in Interview : Career opportunity in CIPLA for QC - 50 vacancies

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.